Showing 361-370 of 3545 results for "".
Join Us for NewDerm LIVE: Welcome from the Chairs
https://practicaldermatology.com/topics/practice-management/join-us-for-newderm-live-welcome-from-the-chairs/18920/Join us September 18-20, 2015 at the W Hollywood, CA for NewDerm Live, the meeting that's focused on you—so you can focus on your future. Program chairs Sabrina Fabi, MD, Peter Lio, MD, and Kavita Mariwalla, MD, talk about the goals of the meeting and explain why they decided to be part of this exciLink Building Basics, an Ekwa.com Educational Video
https://practicaldermatology.com/topics/practice-management/link-building-basics-understanding-the-need-for-a-robust-linkbuilding-program/19331/Link building is all about getting other websites across the Internet "link back" to your website. Backlinks are Google's way of measuring the quality and popularity of your website based on the recommendation of others. Visit Ekwa.com for more information.Advanced Live Patient Workshop on Fillers: NASHA
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/advanced-live-patient-workshop-on-fillers-nasha/19392/LIVE Patient DemonstrationsHS Tips and Lizards
https://practicaldermatology.com/series/the-practical-dermatology-podcast/hs-tips-and-lizards/35858/The latest news and updates, plus a psoriasis update from Jashin J. Wu, MD, FAAD, at Music City SCALE, and Jennifer L. Hsiao, MD, joins Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, to discuss treating hidradenitis suppurativa and play a game of "Two Truths and a Lie."Depression and Psoriasis: What’s the Link?
https://practicaldermatology.com/topics/psoriasis/depression-and-psoriasis-whats-the-link/19652/Can depression lead to psoriasis or are psoriasis patients at an increased risk for depression? Ronald Prussick, MD talks about the link and what you and your patients should know.Update on Pediatric Vulvar Lichen Sclerosis
https://practicaldermatology.com/topics/general-topics/update-on-pediatric-vulvar-lichen-sclerosis/18733/Pediatric vulvar lichen sclerosis may be under-recognized. Pediatric dermatologist Kalyan Marathe, MD talks to host Adam Friedman, MD about the importance of identifying and treating the condition, providing relief to patients and potentially avoiding unnecessary testing.Topical Toxins: Now and Later
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/topical-toxins-now-and-later/18768/Topical neurotoxins are in late-stage development, with the potential to offer "softer" results and reduction of fine wrinkles. But they may not be approved for another few years. In the meantime, micro channel delivery of toxins, such as with AquaGold, is an option. Joel Schlessinger, MD, founder oSkin cancer: Coach's toughest opponent [Full-length]
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-full-length-/18921/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofSkin cancer: Coach's toughest opponent: PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-psa/18922/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)